Skip to main content
. Author manuscript; available in PMC: 2024 Dec 25.
Published in final edited form as: Clin Exp Rheumatol. 2020 Sep 3;39(3):519–524. doi: 10.55563/clinexprheumatol/7kyr5e

Table III.

Nuclear indirect immunofluorescence pattern in the different myositis subsets compared to the healthy comparators.

HC
(n=31)
DM
(n=42)
IBM
(n=18)
PM
(n=34)
Fine speckled 39% (12)* 64% (27)* 61% (11) 56% (19)
Homogeneous 29% (9)** 10% (4)* 6% (1) 0% (0)***
Nuclear large/coarse speckled 13% (4) 10% (4) 6% (1) 3% (1)
Centromere 6% (2) 0% (0) 0% (0) 6% (2)
Nucleolar homogeneous 6% (2) 7% (3) 6% (1) 18% (6)
Nucleolar clumpy 3% (1) 2% (1) 6% (1) 6% (2)
Topo I speckled 3% (1) 0% (0) 0% (0) 0% (0)
Nuclear envelope punctate 0% (0) 2% (1) 11% (2) 6% (2)
Nuclear envelope smooth 0% (0) 0% (0) 6% (1) 0% (0)
Dense fine speckled 0% (0) 2% (1) 0% (0) 0% (0)
Discrete nuclear dots multiple 0% (0) 2% (1) 0% (0) 3% (1)
Nucleolar envelope punctate 0% (0) 0% (0) 0% (0) 3% (1)
*

p<0.05,

**

p<0.01,

***

p<0.001.

Dichotomous variables were shown as %(n) and compared using the Chi-squared or Fisher’s exact tests, as appropriate. Each group was compared with the healthy comparators.

HC: healthy comparator; DM: dermatomyositis; IBM: inclusion body myositis; PM: polymyositis.